• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ligand Pharmaceuticals Incorporated - Common Stock (NQ:LGND)

309.07 -2.94 (-0.94%)
Streaming Delayed Price Updated: 10:32 AM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 55,896
Open 314.81
Bid (Size) 309.07 (100)
Ask (Size) 311.91 (200)
Prev. Close 312.01
Today's Range 309.07 - 316.29
52wk Range 111.72 - 320.99
Shares Outstanding 16,676,532
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Ligand Pharmaceuticals Director Unloads 2,501 Shares — Should You Be Concerned? ↗
June 14, 2026
This biotech innovator, known for its royalty-driven model, reported a notable insider sale amid a period of strong share price gains. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million ↗
June 07, 2026
Biotech royalty player Ligand Pharmaceuticals reported a notable insider sale following a year of strong stock performance. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+62.6%
+62.6%
1 Month
+34.5%
+34.5%
3 Month
+54.8%
+54.8%
6 Month
+63.5%
+63.5%
1 Year
+174.6%
+174.6%

More News

Read More
News headline image
Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy? ↗
May 30, 2026
Via The Motley Fool
Topics Regulatory Compliance
Ligand Pharmaceuticals (NASDAQ:LGND) Shares Fall on Q1 Revenue and EPS Miss ↗
May 07, 2026
Via Chartmill
Ligand Pharmaceuticals (NASDAQ:LGND) Passes Minervini Trend Template and Growth Screen ↗
April 01, 2026
Via Chartmill
Ligand Pharmaceuticals (NASDAQ:LGND) Beats Q4 Estimates and Reaffirms 2026 Guidance ↗
February 26, 2026
Via Chartmill
News headline image
OneSpaWorld Posted Record Revenue for Last Quarter. Why Did a Fund Exit a $21.5 Million Stake? ↗
May 29, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Is Genpact Stock a Buy After Hedge Fund Rice Hall James Raised Its Stake by $14 Million? ↗
May 19, 2026
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares? ↗
May 16, 2026
Via The Motley Fool
Topics Initial Public Offering
News headline image
Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
May 12, 2026
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
News headline image
Ligand (LGND) Q1 2026 Earnings Call Transcript ↗
May 12, 2026
Via The Motley Fool
Topics Earnings
News headline image
Ligand Pharmaceuticals Q1 Earnings Call Highlights ↗
May 08, 2026
Via MarketBeat
Topics Earnings
News headline image
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
May 06, 2026
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
May 05, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Villere St Denis Liquidates $18 Million Euronet Worldwide Stake, According to Recent SEC Filing ↗
May 04, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Villere St Denis Dumps 134,000 Tidewater (TDW) Shares Worth $9.3 Million ↗
May 02, 2026
Via The Motley Fool
Topics Energy Regulatory Compliance
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
April 27, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
April 27, 2026
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
CLO Sells LGND 5,000 Shares for $1.0 Million ↗
March 30, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know ↗
March 27, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Rice Hall James Buys QuidelOrtho Stock ↗
March 09, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Rice Hall James Buys Stride Stock ↗
March 09, 2026
Via The Motley Fool
News headline image
Ligand Pharma (LGND) Earnings Call Transcript ↗
February 26, 2026
Via The Motley Fool
Topics Earnings
News headline image
The Great Rotation: Small-Caps Break the Mega-Cap Monopoly in Early 2026
February 23, 2026
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
This $38.8 Million Vicor Bet Is Getting Bigger Amid a 200% Stock Surge ↗
February 17, 2026
Via The Motley Fool

Frequently Asked Questions

Is Ligand Pharmaceuticals Incorporated - Common Stock publicly traded?
Yes, Ligand Pharmaceuticals Incorporated - Common Stock is publicly traded.
What exchange does Ligand Pharmaceuticals Incorporated - Common Stock trade on?
Ligand Pharmaceuticals Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock?
The ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock is LGND on the Nasdaq Stock Market
What is the current price of Ligand Pharmaceuticals Incorporated - Common Stock?
The current price of Ligand Pharmaceuticals Incorporated - Common Stock is 309.07
When was Ligand Pharmaceuticals Incorporated - Common Stock last traded?
The last trade of Ligand Pharmaceuticals Incorporated - Common Stock was at 07/02/26 10:32 AM ET
What is the market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock?
The market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock is 5.15B
How many shares of Ligand Pharmaceuticals Incorporated - Common Stock are outstanding?
Ligand Pharmaceuticals Incorporated - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap